RBC Capital Remains a Buy on Precision Drilling (PDS)
RBC Capital analyst Keith Mackey maintained a Buy rating on Precision Drilling (PDS – Research Report) yesterday and set a price target of C$89.00. The company's shares closed yesterday at $47.01.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Mackey covers the Energy sector, focusing on stocks such as Baker Hughes Company, Patterson-UTI, and Atlas Energy Solutions. According to TipRanks, Mackey has an average return of 16.9% and a 56.70% success rate on recommended stocks.
Currently, the analyst consensus on Precision Drilling is a Strong Buy with an average price target of $68.13.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Corebridge enters $2.8B reinsurance agreement with CS Life Re
Corebridge (CRBG) Financial earlier announced that it has entered into an agreement with CS Life Re, a subsidiary of Venerable Holdings, to reinsure all the variable annuities of its Individual Retirement business, with account value totaling $51B as of March 31, 2025. The transaction is valued at $2.8B, consisting of both ceding commission and capital release, and will generate approximately $2.1B of net distributable proceeds after-tax for Corebridge. Kevin Hogan, President and CEO of Corebridge, said, 'This is a transformative transaction that repositions the company by exiting Individual Retirement variable annuities. This transaction delivers significant value for Corebridge and its shareholders. We are reaffirming our financial targets while reducing risk and maintaining our diversified business model. We expect to use the proceeds to accelerate our capital management objectives, including a substantial majority returned via share repurchases, with the remainder to support organic growth. Our Board of Directors approved a $2B increase to our share repurchase authorization in connection with this transaction.' Shares of Corebridge Financial are up nearly 6% to $34.97 in morning trading. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on CRBG: Disclaimer & DisclosureReport an Issue Corebridge Financial Announces Major Reinsurance Transaction Corebridge Financial Elects Directors at Annual Meeting Corebridge participates in a conference call with JPMorgan Corebridge price target raised to $37 from $32 at Morgan Stanley Soros buys JPMorgan, exits Alibaba in Q1
Yahoo
30 minutes ago
- Yahoo
Mettler-Toledo price target raised to $1,260 from $1,200 at BofA
BofA raised the firm's price target on Mettler-Toledo (MTD) to $1,260 from $1,200 and keeps a Neutral rating on the shares. The firm is updating its price targets for stocks under its coverage in the Life Sciences & Diagnostic Tools, LSTs, sector, the analyst tells investors. The firm notes LSTs remain under pressure as uncertainty persists with the macro environment and U.S. government policies. Recent weeks, however, have seen some signs of improvement as tariff concerns have cools slightly, the firm adds. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on MTD: Disclaimer & DisclosureReport an Issue Mettler-Toledo initiated with an Overweight at Barclays Citi adds 'upside 90-day short-term view' on Mettler-Toledo MongoDB and Asana downgraded: Wall Street's top analyst calls UBS upgrades Mettler-Toledo to Buy into growth reacceleration UBS upgrades Mettler-Toledo to Buy ahead of growth reacceleration Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
Yahoo
30 minutes ago
- Yahoo
Revvity price target lowered to $110 from $116 at BofA
BofA lowered the firm's price target on Revvity (RVTY) to $110 from $116 and keeps a Buy rating on the shares. The firm is updating its price targets for stocks under its coverage in the Life Sciences & Diagnostic Tools, LSTs, sector, the analyst tells investors. The firm notes LSTs remain under pressure as uncertainty persists with the macro environment and U.S. government policies. Recent weeks, however, have seen some signs of improvement as tariff concerns have cools slightly, the firm adds. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on RVTY: Disclaimer & DisclosureReport an Issue Revvity announces launch of three Mimix reference standards for IVD use Citi adds 'upside 90-day short-term view' on Revvity Revvity upgraded to Buy from Neutral at UBS Revvity Reports Strong Q1 2025 Financial Results Revvity's Resilience and Strategic Positioning Earns Buy Rating Amidst Macroeconomic Challenges Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
